1ody: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1ody.jpg|left|200px]] | [[Image:1ody.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_1ody", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_1ody| PDB=1ody | SCENE= }} | ||
}} | |||
'''HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130''' | '''HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130''' | ||
| Line 24: | Line 21: | ||
Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV., Kervinen J, Lubkowski J, Zdanov A, Bhatt D, Dunn BM, Hui KY, Powell DJ, Kay J, Wlodawer A, Gustchina A, Protein Sci. 1998 Nov;7(11):2314-23. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9827997 9827997] | Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV., Kervinen J, Lubkowski J, Zdanov A, Bhatt D, Dunn BM, Hui KY, Powell DJ, Kay J, Wlodawer A, Gustchina A, Protein Sci. 1998 Nov;7(11):2314-23. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9827997 9827997] | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Gustchina, A.]] | [[Category: Gustchina, A.]] | ||
| Line 31: | Line 27: | ||
[[Category: Wlodawer, A.]] | [[Category: Wlodawer, A.]] | ||
[[Category: Zdanov, A.]] | [[Category: Zdanov, A.]] | ||
[[Category: | [[Category: Aid]] | ||
[[Category: | [[Category: Aspartic protease]] | ||
[[Category: | [[Category: Hiv]] | ||
[[Category: | [[Category: Retropepsin]] | ||
[[Category: | [[Category: Retrovirus]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 03:43:34 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
Revision as of 03:43, 3 May 2008
HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130
OverviewOverview
One of the major problems encountered in antiviral therapy against AIDS is the emergence of viral variants that exhibit drug resistance. The sequences of proteases (PRs) from related retroviruses sometimes include, at structurally equivalent positions, amino acids identical to those found in drug-resistant forms of HIV-1 PR. The statine-based inhibitor LP-130 was found to be a universal, nanomolar-range inhibitor against all tested retroviral PRs. We solved the crystal structures of LP-130 in complex with retroviral PRs from HIV-1, feline immunodeficiency virus, and equine infectious anemia virus and compared the structures to determine the differences in the interactions between the inhibitor and the active-site residues of the enzymes. This comparison shows an extraordinary similarity in the binding modes of the inhibitor molecules. The only exceptions are the different conformations of naphthylalanine side chains at the P3/P3' positions, which might be responsible for the variation in the Ki values. These findings indicate that successful inhibition of different retroviral PRs by LP-130 is achieved because this compound can be accommodated without serious conformational differences, despite the variations in the type of residues forming the active-site region. Although strong, specific interactions between the ligand and the enzyme might improve the potency of the inhibitor, the absence of such interactions seems to favor the universality of the compound. Hence, the ability of potential anti-AIDS drugs to inhibit multiple retroviral PRs might indicate their likelihood of not eliciting drug resistance. These studies may also contribute to the development of a small-animal model for preclinical testing of antiviral compounds.
About this StructureAbout this Structure
1ODY is a Single protein structure of sequence from Human immunodeficiency virus type 1 (isolate hxb2). Full crystallographic information is available from OCA.
ReferenceReference
Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV., Kervinen J, Lubkowski J, Zdanov A, Bhatt D, Dunn BM, Hui KY, Powell DJ, Kay J, Wlodawer A, Gustchina A, Protein Sci. 1998 Nov;7(11):2314-23. PMID:9827997 Page seeded by OCA on Sat May 3 03:43:34 2008